Here, we performed a longitudinal PET study using a novel tau-selective PET tracer, [18F]THK-5117, in order to investigate the sequential changes in the spatial distribution of tau and its association with cognitive decline in patients with AD. The gene discussed is MAPT; the disease is Alzheimer disease.